Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function

BACKGROUND: Delocalization of neuronal nitric oxide synthase (nNOS) from the sarcolemma leads to functional muscle ischemia. This contributes to the pathogenesis in cachexia, aging and muscular dystrophy. Mutations in the gene encoding dystrophin result in Duchenne muscular dystrophy (DMD) and Becke...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Junling, Yang, Hsiao Tung, Wasala, Lakmini, Zhang, Keqing, Yue, Yongping, Duan, Dongsheng, Lai, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607532/
https://www.ncbi.nlm.nih.gov/pubmed/31266455
http://dx.doi.org/10.1186/s10020-019-0101-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607532/
https://www.ncbi.nlm.nih.gov/pubmed/31266455
http://dx.doi.org/10.1186/s10020-019-0101-6

Ejemplares similares